Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease

Parkinsonism and Related Disorders

Volumn 21, Issue 8, 2015, Pages 923-928

  Li, Dun Hui ^a   Zhang, Lin Yuan ^a   Hu, Yun Yun ^a   Jiang, Xu Feng ^a   Zhou, Hai Yan ^a   Yang, Qiong ^a   Kang, Wen Yan ^a   Liu, Jun ^a   Chen, Sheng Di ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Echogenicity; Parkinson's disease; SPECT; Transcranial sonography

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRODAT-1; TROPANE DERIVATIVE;

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN RADIOGRAPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DOPAMINERGIC SYSTEM; DOPPLER ECHOGRAPHY; FEMALE; HOEHN AND YAHR SCALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PUTAMEN; RADIOLOGICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; ECHOGRAPHY; MIDDLE AGED; PROCEDURES; SCINTISCANNING; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84937514651     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.05.024     Document Type: Article

References (30)

1. Bajaj N.P., Gontu V., Birchall J., Patterson J., Grosset D.G., Lees A.J. Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J.Neurol. Neurosurg. Psychiatry 2010, 81:1223-1228.
2. Stoessl A.J. Neuroimaging in the early diagnosis of neurodegenerative disease. Transl. Neurodegener. 2012, 1:5.
3. Kung M.P., Stevenson D.A., Plossl K., Meegalla S.K., Beckwith A., Essman W.D., et al. [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur. J. Nucl. Med. 1997, 24:372-380.
4. Hwang W.J., Yao W.J., Wey S.P., Ting G. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. J.Nucl. Med. 2004, 45:207-213.
5. Weng Y.H., Yen T.C., Chen M.C., Kao P.F., Tzen K.Y., Chen R.S., et al. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. J.Neural Transm. 2004, 45:393-401.
6. Berg D., Becker G. Perspectives of B-mode transcranial ultrasound. Neuroimage 2002, 15:463-473.
7. Behnke S., Berg D., Naumann M., Becker G. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J.Neurol. Neurosurg. Psychiatry 2005, 76:423-425.
8. Berg D., Roggendorf W., Schroder U., Clein R., Tatschner T., Benz P., et al. Echogenicity of the substantia nigra association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch. Neurol. 2002, 59:999-1005.
9. Berg D., Grote C., Rausch W.D., Maurer M., Wesemann W., Riederer P., et al. Iron accumulation in the substantia nigra in rats visualized by ultrasound. Ultrasound Med. Biol. 1999, 25:901-904.
10. Walter U., Wittstock M., Benecke R., Dressler D. Substantia nigra echogenicity is normal in non extrapyramidal cerebral disorder but increased in Parkinson's disease. J.Neural Transm. 2002 Feb 109, 191-196.
11. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J.Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
12. Kang W.Y., Yang Q., Jiang X.F., Chen W., Zhang L.Y., Wang X.Y., et al. Salivary DJ-1 could be an indicator of Parkinson's disease progression. Front. Aging Neurosci. 2014, 6:102.
13. Chen W., Tan Y.Y., Hu Y.Y., Zhan W.W., Wu L., Lou Y., et al. Combination of olfactory test and substantia nigra transcranial sonopraphy in the differential diagnosis of Parkinson's disease: a pilot study from China. Transl. Neurodegener. 2012, 1:25.
14. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
15. Bor-Seng-Shu E., Pedroso J.L., Felicio A.C., de Andrade D.C., Teixeira M.J., Braga-Neto P., et al. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study. Park. Relat. Disord. 2014, 20:477-481.
16. Bartova P., Kraft O., Bernatek J., Havel M., Ressner P., Langova K., et al. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders. Ultrasound Med. Biol. 2014, 40:2365-2371.
17. DeLong M.R., Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch. Neurol. 2007, 64:20-24.
18. Weise D., Lorenz R., Schliesser M., Schirbel A., Reiners K., Classen J. Substantia nigra echogenicity: a structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Mov. Disord. 2009, 24:1669-1675.
19. Berg D., Merz B., Reiners K., Naumann M., Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov. Disord. 2005, 20:383-385.
20. Zecca L., Berg D., Arzberger T., Ruprecht P., Rausch W.D., Musicco M., et al. Invivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov. Disord. 2005, 20:1278-1285.
21. Kim J.Y., Kim S.T., Jeon S.H., Lee W.Y. Midbrain transcranial sonography in Korean patients with Parkinson's disease. Mov. Disord. 2007, 22:1922-1926.
22. Izawa M.O., Miwa H., Kajimoto Y., Kondo T. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease. Eur. J. Neurol. 2012, 19:411-416.
23. Behnke S., Double K.L., Duma S., Broe G.A., Guenther V., Becker G., et al. Substantia nigra echomorphology in the healthy very old: correlation with motor slowing. Neuroimage 2007, 34:1054-1059.
24. Liepelt I., Behnke S., Schweitzer K., Wolf B., Godau J., Wollenweber F., et al. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population. Neurobiol. Aging 2011, 32:1599-1606.
25. Walter U., Hoeppner J., Prudente-Morrissey L., Horowski S., Herpertz S.C., Benecke R. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 2007, 130:1799-1807.
26. Huang Y.W., Jeng J.S., Tsai C.F., Chen L.L., Wu R.M. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease. Mov. Disord. 2007, 22:550-555.
27. Menendez-Gonzalez M., Tavares F., Zeidan N., Salas-Pacheco J.M., Arias-Carrion O. Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study. Front. Aging Neurosci. 2014, 6:56.
28. Silveira-Moriyama L., Schwingenschuh P., O'Donnell A., Schneider S.A., Mir P., Carrillo F., et al. Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J.Neurol. Neurosurg. Psychiatry 2009, 80:744-748.
29. Schwingenschuh P., Ruge D., Edwards M.J., Terranova C., Katschnig P., Carrillo F., et al. Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov. Disord. 2010, 25:560-569.
30. Vlaar A.M., de Nijs T., van Kroonenburgh M.J., Mess W.H., Winogrodzka A., Tromp S.C., et al. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans. BMC Neurol. 2008, 8:42.